AmerisourceBergen Corporation reported a 3.8% increase in revenue for the fourth quarter of fiscal year 2022, reaching $61.2 billion. GAAP diluted EPS was $1.40, while adjusted diluted EPS increased by 8.8% to $2.60. The company's performance was driven by growth in U.S. Healthcare Solutions, offset by a decrease in International Healthcare Solutions due to foreign currency translation.
Revenue increased by 3.8% to $61.2 billion in the fourth quarter of fiscal 2022.
GAAP diluted EPS was $1.40 for the quarter.
Adjusted diluted EPS increased by 8.8% to $2.60 in the fiscal fourth quarter.
U.S. Healthcare Solutions revenue increased by 4.7%, while International Healthcare Solutions revenue decreased by 2.7%.
AmerisourceBergen introduced its fiscal year 2023 financial guidance, expecting revenue growth in the range of 5 to 7 percent and adjusted diluted earnings per share to be in the range of $11.30 to $11.60, representing growth of 2 to 5 percent.